Abstract |
Forty-nine of 52 (94.2%) children with musculoskeletal infection (MSKI) were successfully treated with cefadroxil dosed at 30 mg/kg/day over a 10-year time period. Two failures were associated with poor medication adherence. Our study suggests that treatment of MSKI with cefadroxil offers acceptable outcomes. Confirmation through clinical trials is appropriate.
|
Authors | Erin Weslander, Holly Thomas, Ralph Jeune, Michael Green, John V Williams |
Journal | Journal of the Pediatric Infectious Diseases Society
(J Pediatric Infect Dis Soc)
Vol. 11
Issue 12
Pg. 590-593
(Dec 28 2022)
ISSN: 2048-7207 [Electronic] England |
PMID | 36112393
(Publication Type: Journal Article)
|
Copyright | © The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: [email protected]. |
Chemical References |
|
Topics |
- Child
- Humans
- Cefadroxil
(therapeutic use)
- Hospitals, Pediatric
|